SANUWAVE Health, Inc. (SNWV) - Dilution Analysis

10-Q filing | 8.6M shares outstanding

10-K filing | 8.6M shares outstanding

10-Q filing | 8.6M shares outstanding

10-Q filing | 8.6M shares outstanding

10-Q filing | 8.5M shares outstanding

10-K filing | 8.5M shares outstanding

S-1 filing: The offering consists of 2,887,156 shares of common stock offered by selling stockholders.

10-Q filing | 8.5M shares outstanding

8-K filing | Stock split 1-for-375 | Outstanding: 1,182,598,000 → 3,153,594 | Transactions: Sale 1300000 Common stock $10.3M to Purchasers named in the securities purchase agreement; Issuance 3989456 Common stock; Issuance 146302 Common stock | Proceeds: $10.3M

10-Q filing | 1182.6M shares outstanding

8-K filing: Sanuwave Health, Inc. completed a private placement on June 18, 2024, issuing convertible promissory notes and warrants for common stock, generating total proceeds of $1.8 million.

10-Q filing | 1162.3M shares outstanding

10-K filing | 1140.6M shares outstanding

8-K filing: Sanuwave Health, Inc. closed a private placement on January 21, 2024, issuing Future Advance Convertible Promissory Notes with an aggregate principal amount of approximately $4.6 million and warrants to purchase 227.8 million shares of common stock, receiving no cash proceeds.

8-K filing: SANUWAVE Health, Inc. completed a private placement on December 30, 2023, issuing approximately $1.9 million in future advance convertible promissory notes, warrants to purchase 46.5 million shares of common stock with an exercise price of $0.067 per share, and warrants to purchase 46.5 million shares of common stock with an exercise price of $0.04 per share, receiving total proceeds of $1.8 million.

10-Q filing | 1026.1M shares outstanding

S-1/A filing: This prospectus relates to the possible resale or other disposition, from time to time, of up to 96,687,519 shares of our common stock by the selling stockholders named in this prospectus.

10-Q filing | 1026.1M shares outstanding

S-1 filing: This prospectus relates to the possible resale or other disposition, from time to time, of up to 96,687,519 shares of our common stock by the selling stockholders named in this prospectus.

10-Q filing | 575.0M shares outstanding

10-K filing | 549.5M shares outstanding

S-1/A filing: This S-1/A filing registers 1,929,282,686 shares of common stock for resale by selling stockholders, including shares issuable upon exercise of warrants, conversion of notes, and shares issued under various agreements.

S-1/A filing: This prospectus relates to the possible resale or other disposition, from time to time, of up to 1,929,282,686 shares of our common stock by the selling stockholders named in this prospectus.

10-Q filing | 561.1M shares outstanding

S-1 filing: This prospectus relates to the possible resale or other disposition, from time to time, of up to 1,294,689,945 shares of our common stock by the selling stockholders named in this prospectus.

10-Q filing | 538.6M shares outstanding

8-K filing: SANUWAVE Health, Inc. entered into a Securities Purchase Agreement for a private placement involving convertible notes and warrants, and also settled a prior agreement by issuing shares and cash. ($3.21M proceeds)

RW filing: SANUWAVE Health, Inc. requests withdrawal of Registration Statement on Form S-1 (File No. 333-249325) because it is no longer pursuing a public offering of securities at this time.

10-Q filing | 525.4M shares outstanding

10-K filing | 518.4M shares outstanding

8-K filing: SANUWAVE Health, Inc. entered into a Second Amendment to Note and Warrant Purchase and Security Agreement, providing for the sale and purchase of $3,000,000 in secured notes and the issuance of 20,666,993 shares of Common Stock as advisory shares.

10-Q filing | 518.3M shares outstanding

10-Q filing | 518.3M shares outstanding

10-Q filing | 470.7M shares outstanding

10-K filing | 293.8M shares outstanding

8-K filing: SANUWAVE Health, Inc. completed a private placement on September 7, 2021, issuing future advance convertible promissory notes with an aggregate principal amount of up to $543,478 and warrants to purchase 2,777,779 shares of common stock.

8-K filing: SANUWAVE Health, Inc. entered into a Securities Purchase Agreement with Leviston Resources, LLC for the sale of a convertible promissory note and a warrant to purchase common stock.

10-Q filing | 466.1M shares outstanding

S-1 filing: The filing is for the registration of resale of common stock by selling stockholders and upon exercise of warrants.

10-Q filing | 302.1M shares outstanding

10-Q filing | 298.7M shares outstanding

POS AM filing: This is a POS AM filing detailing a prior private placement completed in March 2014 consisting of common stock, preferred stock, warrants and convertible notes.

POS AM filing: The company entered into a Common Stock Purchase Agreement with accredited investors for the sale of 21,071,143 shares of common stock at $0.14 per share, short term notes payable agreements in the total principal amount of $210,000 via issuance of 2,250,000 shares of common stock and filed a Certificate of Designation of Preferences, Right and Limitations of Series C Convertible Preferred Stock of the Company with the Nevada Secretary of State which amended our Articles of Incorporation to designate 90 shares of our preferred stock as Series C Convertible Preferred Stock.

10-K filing | 293.8M shares outstanding